Trial intelligence / Profile preview

Tranexamic acid versus misoprostol for reducing blood loss during cesarean section

PACTR201910644489698Completed

Sponsor
Christian O OGAH
Start
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of tranexamic acid and misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by Christian O OGAH. Primary endpoint: Quantity of blood loss during cesarean section. Started Jan 2017; status: completed.

02

Drugs

tranexamic acidmisoprostol
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on PACTR201910644489698.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201910644489698.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call